Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-836
Closed -$72K 157
2022
Q3
$72K Sell
836
-51
-6% -$4.55K 0.11% 74
2022
Q2
$81K Sell
887
-7
-0.8% -$621 0.12% 68
2022
Q1
$73K Buy
894
+44
+5% +$3.47K 0.13% 68
2021
Q4
$65K Buy
+850
New +$67.7K 0.12% 72

Other funds holding MRK

Andrew C. Karlinski's MRK Position: Q4 2022 in Review

Andrew C. Karlinski sold out of Merck (MRK) in Q4 2022, closing a stake of 836 shares — an estimated $72K sold.

Andrew C. Karlinski first reported a position in MRK in Q4 2021 and held it in 4 quarters. The position peaked at $81K in Q2 2022. 3,234 funds tracked by Wall St. Rank hold MRK as of Q4 2022.

  • Andrew C. Karlinski reported no remaining Merck position as of Q4 2022 after selling out during the quarter.
  • Andrew C. Karlinski sold 836 Merck shares in Q4 2022, an estimated $72K.
  • Andrew C. Karlinski first reported a position in Merck in Q4 2021 and held it in 4 quarters.
  • Andrew C. Karlinski's Merck position peaked at $81K in Q2 2022.
  • 3,234 funds tracked by Wall St. Rank held Merck as of Q4 2022.

Based on Andrew C. Karlinski's 13F filing for Q4 2022.